302 related articles for article (PubMed ID: 12761342)
1. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Eur J Neurosci; 2005 Mar; 21(6):1679-88. PubMed ID: 15845095
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1.
Chien WL; Liang KC; Fu WM
Eur J Pharmacol; 2008 Aug; 590(1-3):233-40. PubMed ID: 18590724
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells.
Mejía-García TA; Portugal CC; Encarnação TG; Prado MA; Paes-de-Carvalho R
Cell Signal; 2013 Dec; 25(12):2424-39. PubMed ID: 23958999
[TBL] [Abstract][Full Text] [Related]
6. Long-term potentiation inhibition by low-level N-methyl-D-aspartate receptor activation involves calcineurin, nitric oxide, and p38 mitogen-activated protein kinase.
Izumi Y; Tokuda K; Zorumski CF
Hippocampus; 2008; 18(3):258-65. PubMed ID: 18000819
[TBL] [Abstract][Full Text] [Related]
7. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat.
Mizusawa H; Hedlund P; Brioni JD; Sullivan JP; Andersson KE
J Urol; 2002 May; 167(5):2276-81. PubMed ID: 11956492
[TBL] [Abstract][Full Text] [Related]
9. Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin.
Fukunaga K; Horikawa K; Shibata S; Takeuchi Y; Miyamoto E
J Neurosci Res; 2002 Dec; 70(6):799-807. PubMed ID: 12444602
[TBL] [Abstract][Full Text] [Related]
10. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
Zhuo M; Hu Y; Schultz C; Kandel ER; Hawkins RD
Nature; 1994 Apr; 368(6472):635-9. PubMed ID: 7908417
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation.
Hawkins RD; Zhuo M; Arancio O
J Neurobiol; 1994 Jun; 25(6):652-65. PubMed ID: 8071665
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
[TBL] [Abstract][Full Text] [Related]
13. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
14. BAY 41-2272, a potent activator of soluble guanylyl cyclase, stimulates calcium elevation and calcium-activated potassium current in pituitary GH cells.
Liu YC; Wu SN
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1078-87. PubMed ID: 16445574
[TBL] [Abstract][Full Text] [Related]
15. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
Liu XM; Peyton KJ; Mendelev NN; Wang H; Tulis DA; Durante W
Mol Pharmacol; 2009 Jan; 75(1):208-17. PubMed ID: 18923065
[TBL] [Abstract][Full Text] [Related]
16. YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
Hwang TL; Tang MC; Kuo LM; Chang WD; Chung PJ; Chang YW; Fang YC
Toxicol Appl Pharmacol; 2012 Apr; 260(2):193-200. PubMed ID: 22381622
[TBL] [Abstract][Full Text] [Related]
17. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide/cyclic guanosine monophosphate signaling in the central complex of the grasshopper brain inhibits singing behavior.
Wenzel B; Kunst M; Günther C; Ganter GK; Lakes-Harlan R; Elsner N; Heinrich R
J Comp Neurol; 2005 Jul; 488(2):129-39. PubMed ID: 15924338
[TBL] [Abstract][Full Text] [Related]
19. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
20. Different roles of two nitric oxide activated pathways in spinal long-term potentiation of C-fiber-evoked field potentials.
Zhang XC; Zhang YQ; Zhao ZQ
Neuropharmacology; 2006 May; 50(6):748-54. PubMed ID: 16427664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
